Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1974 5
1975 2
1976 2
1979 1
1981 1
2008 1
2012 1
2013 1
2014 2
2015 3
2016 1
2018 1
2020 3
2021 1
2022 6
2023 5
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.
Morgos DT, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S, Stanescu-Spinu II, Balan DG, Balcangiu-Stroescu AE, Coculescu EC, Georgescu DE, Nica RI. Morgos DT, et al. Among authors: nica s. Int J Mol Sci. 2024 Feb 3;25(3):1848. doi: 10.3390/ijms25031848. Int J Mol Sci. 2024. PMID: 38339127 Free PMC article. Review.
mTOR Dysregulation, Insulin Resistance, and Hypertension.
Stanciu SM, Jinga M, Miricescu D, Stefani C, Nica RI, Stanescu-Spinu II, Vacaroiu IA, Greabu M, Nica S. Stanciu SM, et al. Among authors: nica s. Biomedicines. 2024 Aug 8;12(8):1802. doi: 10.3390/biomedicines12081802. Biomedicines. 2024. PMID: 39200267 Free PMC article. Review.
Assessment of severity of acute pancreatitis over time.
Cofaru FA, Nica S, FierbinȚeanu-Braticevici C. Cofaru FA, et al. Among authors: nica s. Rom J Intern Med. 2020 Jun 1;58(2):47-54. doi: 10.2478/rjim-2020-0003. Rom J Intern Med. 2020. PMID: 32097123 Free article. Review.
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Free article. Clinical Trial.
The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome.
Zenoaga-Barbăroșie C, Berca L, Vassu-Dimov T, Toma M, Nica MI, Alexiu-Toma OA, Ciornei C, Albu A, Nica S, Nistor C, Nica R. Zenoaga-Barbăroșie C, et al. Among authors: nica s. Balkan J Med Genet. 2023 Jul 31;26(1):21-26. doi: 10.2478/bjmg-2023-0003. eCollection 2023 Jul. Balkan J Med Genet. 2023. PMID: 37576792 Free PMC article.
43 results